Ridgetech (NASDAQ:RDGT) Stock Passes Below 200 Day Moving Average – Here’s Why

Posted by Geri Gentry on Aug 12th, 2026

Shares of Ridgetech Inc. (NASDAQ:RDGT – Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $96.93 and traded as low as $0.71. Ridgetech shares last traded at $0.9899, with a volume of 63,212,347 shares.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the company. Weiss Ratings upgraded Ridgetech from a “sell (e+)” rating to a “sell (d)” rating in a research note on Wednesday, August 5th. Wall Street Zen downgraded Ridgetech from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has an average rating of “Sell”.

Get Our Latest Analysis on Ridgetech

Ridgetech Trading Up 6.9%

The stock’s 50 day simple moving average is $1.35 and its 200 day simple moving average is $94.25.

Ridgetech (NASDAQ:RDGT – Get Free Report) last announced its quarterly earnings data on Saturday, August 1st. The company reported ($7.86) earnings per share for the quarter. The business had revenue of $34.68 million for the quarter.

Insider Buying and Selling

In related news, major shareholder Financial Lp Hrt sold 57,998 shares of the business’s stock in a transaction dated Tuesday, June 16th. The stock was sold at an average price of $1.60, for a total value of $92,796.80. Following the completion of the sale, the insider directly owned 61,753 shares of the company’s stock, valued at $98,804.80. The trade was a 48.43% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders sold 72,615 shares of company stock valued at $115,597 in the last three months. 22.60% of the stock is currently owned by company insiders.

Ridgetech Company Profile

(Get Free Report)

China Jo-Jo Drugstores, Inc, together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items.